Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Eligible for Tumor Biopsy”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableStudy completedNCT01791322
What this trial is testing

NovellusDx Tissue Collection Protocol

Who this might be right for
Patients That Have Been Diagnosed With Colorectal CancerPatients Eligible for Tumor Biopsy
Fore Biotherapeutics 15
Not applicableStudy completedNCT03187990
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Who this might be right for
Prostate Cancer
Irene Burger 52
Very early researchActive Not RecruitingNCT02210117
What this trial is testing

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 104
Not applicableActive Not RecruitingNCT06809491
What this trial is testing

One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy

Who this might be right for
Melanoma, SkinAdjuvant Treatment
Central Hospital, Nancy, France 200
Not applicableNot Yet RecruitingNCT06566404
What this trial is testing

Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma

Who this might be right for
Melanoma
European Institute of Oncology 200
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Not applicableStudy completedNCT05961280
What this trial is testing

Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates

Who this might be right for
Ductal Carcinoma in Situ
Gangnam Severance Hospital 385